1.
NON-HODGKIN’S LYMPHOMA OF THE PRIMARY OCULAR ADNEXA-CLINICAL AND HISTOPATHOLOGIC ANALYSIS OF 44 CASES
原发于眼附属器的非何杰金氏淋巴瘤(44例临床病理分析)
2.
Clinical Trial in non-Hodgkin's Lymphoma's Treatment with Escalated CTOP Regimen and Radiotherapy
增强剂量的CTOP方案联合放疗治疗非何杰金氏淋巴瘤的疗效观察
3.
Hereby we present an oral non-Hodgkin’s lymphoma with clinical appearance of gingival hyperplasia.
本病例报告一个发生在口腔的非何杰金氏淋巴瘤，在临床上以牙龈增殖之型式表现出来。
4.
Analysis of NHL Treated with CHOP in 31 Elderly Patients
31例老年人非何杰金淋巴瘤治疗分析
5.
Objective To study the disease of Primary N on-Hodgkin' s Lymphoma of the breast and recognize the effect of the operatio n in its treatments.
目的加深对乳房原发性非何杰金氏恶性淋巴瘤的认识，了解外科手术在该病治疗中的作用。
6.
All cases were confirmed by operation or pathology.
全部病例经手术或活检病理证实,均为非何杰金恶性淋巴瘤。
7.
Image Analysis of the Undifferentiated Carcinoma and NHL of the Nasopharynx
鼻咽未分化癌与非何杰金淋巴瘤的显微图像分析
8.
Relationship Between The Expression Of MDM2 Oncogene And p53 umor Suppressor Gene And Non-Hodgkin Lymphoma In Childhood;
癌基因MDM2和抑癌基因P53的表达与儿童非何杰金淋巴瘤关系的研究
9.
Study on P_(15) Gene Methlation and Reexpression by Demethylation in Non-Hodgkin s Lymphomas;
非何杰金淋巴瘤P15基因甲基化和去甲基化再表达的研究
10.
The Significance of the Expression of Survivin、bcl-6 and on the Prognosis of Non-Hodgkins Lymphoma;
survivin、bcl-6在非何杰金淋巴瘤中的表达及其与预后的关系
11.
CT Diagnosis of Primary Pulmonary non-Hodgkin's Lymphoma
原发性肺非霍奇金氏淋巴瘤的CT诊断
12.
Treatment and Prognostic Analysis of Nasal Non-Hogkin s Lymophoma;
原发鼻腔非霍奇金氏淋巴瘤的治疗及预后分析
13.
Relationship between EBV Infection,Expressions of p53 & p16 and Non Hodgkin s Lymphoma in the Nasal Cavity and Pharyngeal Waldeyer s Ring;
EB病毒感染、p53和p16表达与鼻腔、咽淋巴环非霍奇金氏淋巴瘤的关系
14.
The study on Haploidentical Related Donor Lymphocyte Infusion Versus High-risk Non-Hodgkin,s Lymphoma in Vitro;
半相合供者淋巴细胞输注抗中、高危非霍奇金氏淋巴瘤的实验研究
15.
CT Evaluation of Metastatic and Non-Hodgkin s Lymphoma Lymph Nodes in Abdomen;
腹部肿瘤转移性淋巴结与非霍奇金氏淋巴瘤淋巴结的比较分析—螺旋CT评估
16.
The diagnosis was a form of cancer called non Hodgkin's lymphoma.
詹姆斯被诊断患癌症，叫做非何杰金淋巴瘤，他的爱尔兰天主教大家庭决定让他得到最好的治疗。
17.
The first antibody drug for cancer finally was approved for patients in 1997 for non-Hodgkin's lymphoma.
1997年最先获准用于治疗非霍金森氏淋巴瘤的抗体药物。
18.
Molecular Detection of Clonal Gene Rearrangement in Non-Hodgkin s Lymphoma;
非霍奇金氏淋巴瘤克隆性基因重排分子检测的临床意义